On September 16, the "2020 Top Ten Marketing Cases of Chinese Medicine" award ceremony jointly sponsored by "E Pharmaceutical Manager" magazine and Sandy Brand Consulting was held in Guangzhou. Combined with the two important links of expert review and online voting, the "211 Xinghai Plan" of Xingyin Medicine won the "2020 China Pharmaceutical Marketing Annual Communication Award" by the authoritative assessment of the expert jury.
Affected by the epidemic in 2020, consumers are undergoing structural changes in their own needs, purchasing behaviors and marketing driving forces, especially for prescription drugs entering the retail market. It is necessary to carry out brand operation according to the OTC marketing law, and combine the changes of the epidemic with precise positioning and innovative marketing. In order to win the marketing battle in this affected by the pandemic.
In 2020, Xingyin Pharmaceutical tailored the "211 Xinghai Plan" for the market target of Mai Zhiling\'s products and launched a category of drugs for venous system diseases. With "focusing on key stores and cultivating venous butler" as the starting point, through the scene of "reasonable course of drug use, in-store classroom transformation", we dig deep into the blue ocean of intravenous disease drugs to increase, increase profits and stick customers for chain customers! Star Bank Group team arranges special personnel to put systematic and professional knowledge of venous disease through interactive experiential "small class" form, so that more customers can understand the relationship between the disease and their own, and scientifically manage and treat venous disease, so as to achieve drainage promotion, activate members, improve purchase rate, and coordinate chronic disease management.
On November 24, the "Meis · Project Award" ceremony sponsored by Zhongkang Information was announced at the 2020 MeIS (China Pharmaceutical Retail Mobile Marketing Innovation Conference). After a one-month project audition, data review and comprehensive score, the "211 Xinghai Plan" of Xingyin Pharmaceutical won the "2020 Meisi · Project Award - Top Ten Mobile Sales Projects of Pharmaceutical Retail in China" with excellent performance, sustained influence and outstanding comprehensive performance.
It is reported that MIS Awards, also known as the Chinese Pharmaceutical Retail Innovation Award, is sponsored by the organizing committee of MIS, which is used to recognize the innovation and exploration of Chinese pharmaceutical retail value marketing. The Mesi Award has three permanent awards: enterprise, project and person, and the award ceremony is held at the Mesi Conference (China Pharmaceutical Retail Marketing Innovation Conference) every year. As the only industry honor that promotes the concept of "customer-oriented, value-driven marketing" in China\'s pharmaceutical retail industry, the Mesi Award aims to lead and encourage the transformation and sustainable development of the pharmaceutical retail market.